BACKGROUND AND AIM: Neonatal respiratory distress in full term newborns can be due to several etiologies. Therefore, different clinical features and evolution may be observed. The aim of this study is to determine the particularities of the epidemiology, clinical features and outcomes of respiratory distress in full term newborns. METHOD:It is a retrospective study including 269 full term neonates admitted in the NICU of Sfax, for respiratory distress from January 2013 to December 2014. RESULTS:Neonatal respiratory distress in full term newborns accounted for 8,7% of hospitalizations during the study period. The sex ratio was 1,9. The most common cause was transient tachypnea of the newborn (74,3%) followed by persistent pulmonary hypertension (13,4%), meconium aspiration syndrome (8,2%), respiratory distress syndrome (2,6%), neonatal infection (1,1%) and clear liquid aspiration (0,4%). Delivery was by c-section in 59,0% of cases. It was out of labor in 32,7% of cases. Respiratory management consisted in oxygen administration via hood (79%), nasal continuous positive airway pressure (5,4%) and invasive ventilation (19%). High frequency oscillation ventilation was needed in 7% of cases. The average duration of oxygen administration was 58,5 hours. The most common complications were persistent pulmonary hypertension (11,9%), nosocomial infections (11,2%), and pneumothorax (4,5%). Mortality rate was 2,6%. Only 144 infants were followed till five years. Twelve have presented bronchiolitis and three have developed infant asthma. CONCLUSIONS:Neonatal respiratory distress is common in full term newborns. It is often benign; nevertheless it can be severe and life-threatening. Prognosis can be improved by a better perinatal management.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.